Closed ATM View - Health PH21-27311
Review existing Health Technology Processes as per Commonwealth and Medicines Australia Strategic Agreement
Canberra, Sydney, Melbourne, Adelaide, Perth, Brisbane, Darwin, Hobart
This is a pre-release notice for an upcoming RFT. The RFT is expected to be released in Q1 2022.
The Commonwealth has entered into a new Strategic Agreement with Medicines Australia (the Agreement) acting on behalf of the innovator medicines industry. The Agreement contains a commitment that the Commonwealth support a Health Technology Assessment Policy and Methods Review (the Review). Part of the Review will involve engaging an expert to undertake an analysis of current methods used by the Pharmaceutical Benefits Advisory Committee, contemporary research and relevant methodologies and purchasing practices used by comparable international jurisdictions. The scope of the work sought by the Department may be expanded to also include an examination of the same matters as applicable to the methods used by the Medical Services Advisory Committee (MSAC) to ensure consistency across HTA.
1 The contractor will be required to undertake that analysis under the direction of a Reference Committee for the Review and will include, but not be limited to, analysis of contemporary research and methodologies used by comparable jurisdictions in relation to:
o selection of comparators
o methods for evaluating rare diseases for reimbursement and alternative funding pathways if required
o methods for evaluating new and emerging technologies (including cell and gene therapies, and other precision-based medicines) and the suitability of existing funding pathways as required
o methods for evaluating all new medicines and vaccines
o use of real-world evidence for evaluation including use of evidence from sources other than randomised controlled trials
o managing clinical, economic, financial, and other uncertainty
o examining the feasibility of international work sharing for reimbursement submissions
2 Perform additional project work on an as needs basis and sometimes in a short timeframe. This may include the analysis of relevant broader microeconomic policies and methodologies used to make funding decisions in areas that go beyond health technology assessment; outcomes of reforms to health technology assessment in comparable jurisdictions; and summarising submissions to the review from patients, industry, health practitioners and relevant representative bodies.
3 Provide draft and final reports that detail the findings of the analysis.
4 Attend meetings held by the Reference Committee for the Review and discussions with relevant officers in the Department.
The Tenderer must not have had any judicial decisions against it (excluding decisions under appeal) relating to employee entitlements and have not paid the claim.
The Tenderer, its personnel, and any Subcontractors proposed in the Tender must not, at the Closing Time, be listed as terrorists under section 15 of the Charter of the United Nations Act 1945 (Cth).
The Tenderer (and any Subcontractor proposed in its Tender) must not be named in the Consolidated list referred to in Regulation 40 the Charter of United Nations (Dealing with Assets) Regulations 2008 (Cth).
01 July 2022 – Contract Start Date
30 June 2024 – Contract End Date
Extension Option Three (3) by 12 months periods.
Nil